All the News

HAYA's CEO Sees a Future Where His Therapy Could Treat Cancer and Alzheimer’s

swissinfo.ch

@haya 25 Oct '25

Press Release

HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs®

To Accelerate Development of RNA-Guided Therapeutics Platform

@haya 3 Jun '25

Press Release

HAYA Therapeutics Raises $65 Million in Series A Funding

To Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

@haya 8 May '25

Press Release

HAYA Therapeutics Announces Collaboration with Lilly

To Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform.

@haya 4 Sep '24

Upcoming Events

Let’s Connect

No upcoming events found.

Filter Categories

View All

Blog

Press Releases

News

Podcasts

Events

Podcast

HAYA's CEO, Samir Ounzain, Shares the Entire Story of Our Journey

A Call to Lead

@haya 6 Nov '25

HAYA's CEO Sees a Future Where His Therapy Could Treat Cancer and Alzheimer’s

swissinfo.ch

@haya 25 Oct '25

Jeffries Healthcare Conference 2025

Meet Samir Ounzain, PhD
HAYA’s CEO & co-founder
and Mihaela Roberts
HAYA’s SVP Finance

London

Mon. 17 – Thu. 20 nov '25

NextGen Omics, Spatial & Data 2025

Meet Marco Mina, PhD
HAYA’s Senior Director, Computational Biology & Data Science

London

Thu. 13 – Fri. 14 nov '25

TIDES Europe 2025

Meet Daniel Blessing, PhD
HAYA’s CTO and co-founder

Basel

Tue. 11 – Thu. 13 nov '25

AHA's Scientific Sessions 2025

Meet Jordan Shin, MD PhD
HAYA’s CMO

New Orleans

Fri. 7 – Mon. 10 nov '25

BIO-EUROPE 2025

Meet Richard Law, PhD
HAYA’s CBO

Vienna

Mon. 3 – Wed. 5 nov '25

Samir Ounzain, HAYA's CEO, Recognized as One of the 100 Personalities Shaping French-Speaking Switzerland

Le Temps

@haya 2 Sep '25